Radiopharma manufacturing + diagnostics + theranostics. Rising sub-node in Manufacture. Public read on radiopharma CDMO capacity. Diagnostic imaging recurring revenue.
Research snapshot · Not reviewed
LNTHLantheus
Radiopharma manufacturing, theranostics
Open LNTH in Robinhood ↗Conviction●○○○○1 of 5
Research target—Snapshot target
Thesis statusNEEDS_MORE_DATALast reviewed Not reviewed
Market cap$7.15BSnapshot value
Radiopharma theranostics adoption (Pluvicto, Lutathera); diagnostic imaging volume growth; radiopharma CDMO capacity expansion; new isotope production.
Radiopharma regulatory/reimbursement pathway still developing; single-product concentration risk; manufacturing complexity (short half-life logistics); competitive entry from large CDMOs.
needs X/Reddit sentiment sweep
Snapshot · Not reviewed🟢 Lean-Bull · 13F 16+/7- · short↑0.32
Snapshot · Not reviewed